Giovanni Luca Frassineti

4PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 27, 2024
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.

Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone

|Aug 26, 2023
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer.

Manlio Monti, Andrea Prochowski Iamurri, David Bianchini

|Apr 13, 2023
Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.

Valentina Zampiga, Ilaria Cangini, Erika Bandini

|Dec 21, 2021
An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study.

Alessandro Passardi, Patrizia Serra, Caterina Donati

Pageof 1

Frequent Collaborators

3 joint publications

Alessandro Passardi

1 joint publications

Patrizia Serra

1 joint publications

Caterina Donati

1 joint publications

Federica Fiori